Centromere antibody and autoantibody reagents: where the antibody is the analyte

Keeping the two uses apart

1. State whether the antibody is reagent or analyte. A reagent detects a target; an autoantibody is the target. Assays, controls and regulatory expectations differ completely, and the same protein name appears in both contexts.
2. Read pattern before titre in autoantibody work. Classical autoantibody testing on a cell substrate reports a staining pattern that suggests a family of specificities, followed by a confirmatory specific assay. The pattern is the screen, not the answer.
3. Detect complement deposition in tissue, not plasma. Deposited fragments in tissue are the informative finding in transplant and immune complex disease. Measuring circulating complement answers a different question about consumption and synthesis.
4. Choose structural reagents for the compartment. Nuclear body, nucleolar, centromere and nuclear pore reagents each give a characteristic pattern that is itself a control. A stain that does not look like the expected structure is a warning.
5. Respect the labelling boundary. Reagents sold for research use may not be used to produce a result that informs clinical care, however capable they are. Where the result will inform care, the assay has to be appropriate to that use.

Same target, two roles

Nuclear and centromeric structures are studied with laboratory reagents and are also the targets of patient autoantibodies, which is not a coincidence: they became known as autoantigens because patient sera stained them.

The overlap makes catalogue searching confusing and the distinction consequential. Say which role you mean, every time.

Patterns are a quality control

Reagents against subnuclear structures produce characteristic, recognisable patterns. That is an unusually good built in control: if the stain does not look like the structure, something is wrong with the reagent or the protocol.

Photograph the expected pattern once on a control sample and keep it with the reagent record.

A lamin a/c antibody and the envelope it outlines

The A type lamins give a sharp nuclear rim, which is the pattern that says the stain worked, and their loss or mislocalisation is the readout in laminopathy and senescence work. A lamin a/c antibody detects both splice forms, and the two bands at roughly seventy and sixty five kilodaltons are the internal check on a blot. Where a mutation is the subject, the clone's epitope position decides whether it survives.

A lamin b antibody as the counterpart at the rim

B type lamins are expressed in nearly every cell and stay at the envelope through differentiation, which makes a lamin b antibody the reference against which a change in the A type lamins is read. It is also the standard marker for the nuclear fraction in a fractionation blot and for envelope integrity in imaging. The two paralogues differ, so the datasheet should say whether the clone sees B1, B2 or both.

A parp antibody and a cleaved parp antibody are two readouts

Full length PARP1 at one hundred and sixteen kilodaltons reports the protein; the eighty nine kilodalton fragment reports caspase activity during apoptosis. A parp antibody raised against the full protein may show both bands, while a cleaved parp antibody is raised against the new neoepitope and only sees the fragment. An apoptosis figure needs whichever of the two the claim rests on, with a treated positive control.

A cdc20 antibody and the narrow window it exists in

The anaphase promoting complex activator is degraded as cells exit mitosis, so a cdc20 antibody reads a synchronised population and reads almost nothing in an unsynchronised one. That makes the synchronisation and the harvest time part of the method rather than a detail. A mitotic marker such as phosphorylated histone H3 on the same lysate is what shows the arrest worked before the band is interpreted.

A pericentrin antibody and centrosome counting

Pericentrin marks the pericentriolar material and is the usual reagent for counting centrosomes, where the readout is the number of foci per cell rather than an intensity. A pericentrin antibody therefore needs a resolution and a scoring rule stated in the method, because two foci close together read as one at low magnification. Cold methanol fixation preserves this structure better than a long formaldehyde step.

A fibrillarin antibody for the nucleolus

Fibrillarin gives a punctate nucleolar pattern that is distinctive enough to act as its own control, which is why a fibrillarin antibody is often used as the nucleolar reference in a colocalisation experiment. It is also one of the antigens autoantibodies recognise in scleroderma, so a clinical reading of the same pattern means something different. The application validated on the datasheet decides which of the two uses it supports.

A cenpa antibody and the centromere it defines

The centromeric histone variant marks the functional centromere rather than the DNA sequence, which is why a cenpa antibody is the reagent for a centromere identity experiment and why its foci count matches the chromosome number. The protein is chromatin bound, so extraction has to reach it, and a chromatin fraction with a histone loading reference is the preparation the datasheet's own images are usually made from.

Common questions

Is a listing for laboratory reagents against an autoantibody something I can buy?

Sometimes both exist under the same name: a laboratory reagent against the structure, and an assay that measures a patient's antibodies against it. Read the product description carefully, because the two are not interchangeable.

What does a staining pattern tell you?

It narrows the likely specificity to a family and directs which confirmatory assay to run. It is a screening result, and reporting it as a specific diagnosis is not supported.

Why measure deposited complement rather than circulating?

Because deposition in tissue localises the process, which is what matters in transplant rejection and immune complex disease. Circulating levels report consumption and synthesis, which is a different question.

Browse by service class

• Compare Gene synthesis on advertised prices